The increased frequencies of circulating DN2 B cells observed in our r-axSpA cohort are also reported in systemic autoimmune diseases [13,37], such as RA and SLE, and validate our previous observation of increased CD27–CD21lo B cell frequencies in another r-axSpA study [7]. Here, CD27 is linked to rheumatoid arthritis.